(Q38328934)

2 September 2017

title

A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer (English)

1 reference

2 September 2017

Hao Hu

1

1 reference

2 September 2017

Yu Liang Wang

2

1 reference

2 September 2017

Gong Wei Wang

3

1 reference

2 September 2017

Yong Chuan Wong

4

1 reference

2 September 2017

Xiao Feng Wang

5

1 reference

2 September 2017

Ying Wang

6

1 reference

2 September 2017

Ke Xin Xu

7

1 reference

2 September 2017

publication date

5 January 2012

1 reference

2 September 2017

1 reference

2 September 2017

volume

31

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

1242-1253

1 reference

2 September 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Expectant management of small, recurrent, noninvasive papillary bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Virtual cystoscopy from computed tomography: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Superficial bladder cancer: progression and recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

The protein Id: a negative regulator of helix-loop-helix DNA binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id family of helix-loop-helix proteins in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Increased expression of Id family proteins in small cell lung cancer and its prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Prognostic significance of Id-1 and its association with EGFR in renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Over expression of ID-1 in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Epithelial-mesenchymal transitions in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Exploring a new twist on tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Expression of E-Cadherin and α-, β-, γ-Catenins in Patients With Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Expression of classic cadherins type I in urothelial neoplastic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Complex networks orchestrate epithelial-mesenchymal transitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Helix-loop-helix proteins in mammary gland development and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Epithelial-mesenchymal transitions: twist in development and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id-1 promotes chromosomal instability through modification of APC/C activity during mitosis in response to microtubule disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.12.003

10.1016/J.UROLONC.2011.12.003

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference